IMPEDIMED LIMITED — Board/Management Information 2015

Jan 7, 2015

==> picture [108 x 100] intentionally omitted <==

----- Start of picture text ----- ASX: IPD----- End of picture text -----

7 January 2015

ASX ANNOUNCEMENT

Company Secretary Appointment

Brisbane, Australia – ImpediMed Limited (ASX: IPD) (“the Company”), is pleased to announce the appointment of Ms Leanne Ralph as Company Secretary effective immediately.

Ms Ralph has 15 years experience providing Company Secretarial services to a range of publicly listed companies in Australia.

Ms Ralph replaces Mr Stephen Denaro who has been Company Secretary since September 2009, and previously from March 2003 through April 2008. The Board would like to thank Mr Denaro for his contribution to the Company over this time.

Cherrell Hirst AO Chairman

About ImpediMed

ImpediMed Limited is the world leader in the development and distribution of medical devices employing Bioimpedance Spectroscopy (BIS) technologies for use in the non-invasive clinical assessment and monitoring of fluid status. ImpediMed’s primary product range consists of a number of medical devices that aid surgeons, oncologists, therapists and radiation oncologists in the clinical assessment of patients for the potential onset of secondary lymphoedema. Pre-operative clinical assessment in cancer survivors, before the onset of symptoms, may prevent the condition from becoming a lifelong management issue and thus improve the quality of life of the cancer survivor. ImpediMed has the first medical device with an FDA clearance in the United States to aid health care professionals, clinically assess secondary unilateral lymphoedema of the arm and leg in women and the leg in men.

For more information, visit: www.impedimed.com.au

Page 1 of 1